After endoscopy, the probability that the patient is positive for ulcer.
Event (BB)
After endoscopy, the probability that the patient is not positive for ulcer.
Event (CC)
After endoscopy and acute treatment, the probability that symptoms resolve.
Event (DO)
After endoscopy and acute treatment, the probability that symptoms do not resolve.
Event (EE)
After endoscopy, acute treatment, and resolution of symptoms, the probability that symptoms recur.
Event (FF)
After endoscopy, acute treatment, and resolution of symptoms, the probability that symptoms do not recur.
Event (GG)
After endoscopy, acute treatment, resolution of symptoms, recurrence, and retreatment, the probability that symptoms 0.9 reso I ve.
.
Event (HH)
After endoscopy, acute treatment, resolution of symptoms, recurrence, and retreatment, the probability that sympto~s 0.1 do not resolve.
Event (II)
After endoscopy, acute treatment, resolution, recurrence, retreatment; resolution, maintenance therapy, the probability 0.75 that the patient is compliant.
Event OJ)
After endoscopy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, the probability 0.25 that the patient is not compliant.
Event (KK)
After endoscopy, acute treatment, resolution, recurrence, retreatment, resolution, and no maintenance therapy, the 0.8 probability that symptoms recur.
Event (lL)
After endoscopy, acute treatment, resolution, recurrence, retreatment, resolution, and no maintenance therapy, the 0.2 probability that symptoms do not recur.
Event (MM)
After endoscopy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, and the patient is 0.25 compliant, the probability that symptoms recur.
Event (NN)
After endoscopy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, and the patient is 0.75 compliant, the probability that symptoms do not recur.
Event (00)
After endoscopy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, and the patient is 0.75 not compliant, the probability that symptoms recur.
Event (PP)
After endoscopy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, and the patient is 0.25 not compliant, the probability that symptoms do not recur.
Event (QQ)
After empiric therapy and acute treatment, the probability that symptoms resolve.
Event (RR)
After empiric therapy and acute treatment, the probability that symptoms do not resolve.
0.25
Event (55) After empiric therapy, acute treatment, and resolution of symptoms, the probability that symptoms recur.
Event (TT)
After empiric therapy, acute treatment, and resolution of symptoms, the probability that symptoms do not recur.
Event (UU)
After empiric therapy, acute treatment, resolution of symptoms, recurrence, and retreatment, the probability that 0.9 symptoms resolve.
Event (VV)
After empiric therapy, acute treatment, resolution of symptoms, recurrence, and retreatment, the probability that 0.1 symptoms do not resolve.
Event (WW)
After empiric therapy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, the 0.75 probability that the patient is compliant Event (XX) After empiric therapy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, the 0.25 probability that the patient is not compliant.
Event (YY)
After empiric therapy, acute treatment, resolution, recurrence, retreatment, resolution, and no maintenance therapy, the 0.8 probability that symptoms recur.
Event (ZZ)
After empiric therapy, acute treatment, resolution, recurrence, retreatment, resolution, and no maintenance therapy, the 0.2 probability that symptóms do not recur.
Event (AAA)
After empiric therapy, acute treatment, resolution, recurrence, retreatment, resolution, maintenance therapy, and the 0.25 patient is compliant, the probability that symptoms recur. therapy, the probability that these patients will be compliant.
Event (BBB)

Event (AG)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are placed on maintenance 0.25 therapy, the probability that these patients will not be compliant.
Event (AH)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are placed on maintenance 0.4 therapy, and are compliant, the probability that symptoms will recur.
Event (AI)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are placed on maintenance 06 therapy, and are compliant, the probability that symptoms will not recur.
Event (AJ)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are placed on maintenance 0.6 therapy, and are not compliant, the probability that symptoms will recur.
Event (AK)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are placed on maintenance 0.4 therapy, and are not compliant, the probability that symptoms will not recur.
Event (BB)
For patients with no history of ulcer, the probability that symptoms recur.
Event (Be)
For patients with no history of ulcer, the probability that symptoms do not recur.
Event (BD)
For patients with no history of ulcer, whose symptoms recur, receive endoscopy, the probability that the endoscopy 0.25
indicates an ulcer.
Event (BE)
For patients with no history of ulcer, whose symptoms recur, receive endoscopy, the probability that the endoscopy 0.75 does not indicate an ulcer.
Event (BF)
For patients with no history of ulcer, whose symptoms recur, who do not receive endoscopy, the probability that symp-0.8 toms resolve after acute treatment and are placed back on maintenance.
Event (BG)
For patients with no history of ulcer, whose symptoms recur, who do not receive endoscopy, the probability that symp-0.2 toms do not resolve after acute treatment.
Event (BH)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, the probability that 0.9 they resolve after acute treatment and are placed back on maintenance therapy.
Event (BI)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, the probability that 0.1 they do not resolve after acute treatment.
Event (BJ)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are 0.75 placed on maintenance therapy, the probability that these patients will be compliant.
Event (BK)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are placed 025 on maintenance therapy, the probability that these patients will be noncompliant.
Event (BL)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute 0.75 treatment, are placed on maintenance therapy, the probability that these patients will be compliant.
Event (BM)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute treatment, are placed on maintenance therapy, the probability that these patients will not be compliant.
Event (BN)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are 0.4 placed back on maintenance therapy, are compliant, the probability that symptoms will recur.
Event (BO)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are 0.6 placed back on maintenance therapy, are compliant, the probability that symptoms will not recur.
Event (BP)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are 0.6 placed back on maintenance therapy, are not compliant, the probability that symptoms will recur.
Event (BQ)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are placed 0.4 back on maintenance therapy, are not compliant, the probability that symptoms will not recur.
Event (BR)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute 0.4 treatment, are placed on maintenance therapy, are compliant, the probability that symptoms will recur.
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Event (BT)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute 0.6 treatment, are placed on maintenance therapy, are not compliant, the probability that symptoms will recur.
Event (BU)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute 0.4 treatment, are placed on maintenance therapy, are not compliant, the probability that symptoms will not recur.
Existing Patients Not on Maintenance Therapy
Name Description Probability Event (CB) For patients with a history of ulcer, the probability that symptoms recur. 0.6
Event (CC)
For patients with a history of ulcer, the probability that symptoms do not recur.
Event (CD)
For patients with a history of ulcer, whose symptoms recur, the probability that symptoms resolve after acute treatment.
Event (CE)
For patients with a history of ulcer, whose symptoms recur, the probability that symptoms do not resolve after acute 0.1 treatment.
Event (CF)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are placed on maintenance 0.75 therapy, the probability that these patients will be compliant.
Event (CG)
Event (CH)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are not placed on maintenance 0.8 therapy, the probability that these symptoms will recur.
Event (Cl)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are not placed on maintenance 0.2 therapy, the probability that these symptoms will not recur.
Event (CJ)
Event (CK)
For patients with a history of ulcer, whose symptoms recur, resolve after acute treatment, are placed on maintenance 0.6 therapy, and are compliant, the probability that symptoms will not recur.
Event (CL)
Event (CM)
Event (DB)
For patients with no history of ulcer, the probability that symptoms recur. 0.7
Event (DC)
Event (DD)
For patients with no history of ulcer, whose symþtoms recur, receive endoscopy, the probability that the endoscopy 0.25
Event (DE)
For patients with no history of ulcer, whose sym'ptoms recur, receive endoscopy, the probability that the endoscopy 0.75
does not indicate an. ulcer.
Event (DF)
For patients with no history of ulcer, whose symptoms recur, who do not receive endoscopy, the probability that 0.8 symptoms resolve after acute treatment.
Event (DG)
For patients with no history of ulcer, whose symptoms recur, who do not receive endoscopy, the probability that 0.2 symptoms do not resolve after acute treatment.
Event (DH)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, the probability that 0.9 they resolve after acute treatment.
Event (Dl)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, the probability that 01 they do not resolve after acute treatment.
Event (D J)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are 0.75 placed on maintenance therapy, the probability that these patients will be compliant. For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are not 0.4 placed on maintenance therapy, the probability that these symptoms will not recur.
Event (DN)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after aéute 0.75 treatment, are placed on maintenance therapy, the probability that these patients will be compliant.
Event (DO)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute 0.25 treatment, are placed on maintenance therapy, the probability that these patients will not be compliant.
Event (DP)
For patients with no history of ulcer, whose symptoms recur, are endoscoped, resolve after acute treatment, are not 0.6 placed on maintenance therapy, the probability that these symptoms will recur.
Event (DQ)
For patients with no history of ulcer, whose symptoms recur, are endoscoped, resolve after acute treatment, are not 0.4 placed on maintenance therapy, the probability that these symptoms will not recur.
Event (DR)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are 0.4 placed on maintenance therapy, are compliant, the probability that symptoms will recur.
Event (DS)
Event (DT)
Event (DU)
For patients with no history of ulcer, whose symptoms recur, are not endoscoped, resolve after acute treatment, are 0.4 placed back on maintenance therapy, are not compliant, the probability that symptoms will not recur.
Event (DV)
Event (DW)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute 0.6 treatment, are placed on maintenance therapy, are compliant, the probability that symptoms will not recur.
"
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute Event (DX) 0.6 treatment, are placed on maintenance therapy, are not compliant, the probability that symptoms will recur.
Event (DY)
For patients with no history of ulcer, whose symptoms recur, are endoscoped and positive for ulcer, resolve after acute 0.4 treatment, are placed on maintenance therapy, are.not compliant, the probability that symptoms will not recur. 
Appendix
Event (F),
After endoscopy, positive test, eradication therapy, symptom recurrence, and administration of eradication test, the 0.9 probability that h.pylori has been not been eradicated and retreatment for eradication.
Event (G)
After endoscopy, positive test, and eradication therapy, symptoms recurrence, no eradication test, and retreatment, the 0.9 probability that symptoms do not recur.
Event (H)
After endoscopy, positive test, and eradication therapy, symptoms recurrence, no eradication test, and retreatment, the 0.1 probability that symptoms recur.
Event (I)
After endoscopy, positive test, eradication therapy, symptom recurrence, and administration of eradication test, indication 0.9 that h.pylori has been not been eradicated and retreatment for eradication, the probability that symptoms do not recur.
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they are tested for eradication, the probability that h.pylon is eradicated and symptoms still persist.
Event (DO)
For existing patients with a history of ulcer by endoscopy or recurrence, receive eradication therapy, symptoms recur, 0.9 they are tested for eradication, the probability that h.pylon is not eradicated and retreatment is administered.
Event (EE)
For existing patients with a history of ulcer by endoscopy or recurrence and who receive eradication therapy, symptoms 0.9 recur, and retreatment is administered, the probability that syrriptoms do not recur.
Event (FF)
For existing patients with a history of ulcer by endoscopy or recurrence and who receive eradication therapy, symptoms 01 . recur, and retreatment is administered, the probability that symptoms recur.
Event (GG)
For existing patients with a history of ulcer by endoscopy or recurrence, receive eradication therapy, symptoms recur, 0.9 they are tested for eradication, h.py/on is not eradicated and retreatment is administered, the probability that symptoms do not recur.
Event (HH)
For existing patients with a history of ulcer by endoscopy or recurrence, receive eradication therapy, symptoms recur, they 0.1 are tested for eradication, h.pylon is not eradicated and retreatment is administered, the probability that symptoms recur.
